Immunitybio, Inc. · NASDAQ:IBRX
Patrick Soon-Shiong reported a 68.90% stake in Immunitybio, Inc. (Schedule 13D/A)
Event Nov 10, 2025 · Filed Nov 10, 2025
Patrick Soon-Shiong reported a 68.90% stake in Immunitybio, Inc., 743,971,200 shares, with active intent on Nov 10, 2025. Filed Nov 10, 2025 (Schedule 13D/A).
- Stake
- 68.90%
- Shares
- 743,971,200
- Intent
- Active
- What changed
- Stake changed
- Filed together
- 7 holders
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| Cambridge Equities, LP | 26.60% | 261,705,814 |
| MP 13 Ventures, LLC | 26.60% | 261,705,814 |
| NantWorks, LLC | 10.00% | 98,535,253 |
| NantMobile, LLC | 4.80% | 47,557,934 |
| Nant Capital, LLC | 31.50% | 339,464,529 |
| California Capital Equity, LLC | 10.80% | 106,511,412 |
| Patrick Soon-Shiong | 68.90% | 743,971,200 |
Source
Related
- Immunitybio, Inc.
- Patrick Soon-Shiong
- Immunitybio, Inc. shareholders
- Schedule 13D/A · Patrick Soon-Shiong · Feb 25, 2026
- Form 4 · Simon Barry J. · Oct 6, 2026
- Form 4 · Cohen Cheryl · Oct 6, 2026
- Schedule 13D/A · Cambridge Equities, LP · Aug 6, 2026
- Form 4 · Cohen Cheryl · Jul 6, 2026
- Form 4 · Selecky Christobel · Jul 6, 2026